netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Daratumumab found 6 matches
Open monograph to display formulary status BNF Category
  Cytotoxic Drug Daratumumab  (Darzalex®) Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA Drug Safety Update (Aug 2019): Daratumumab (Darzalex▼): risk of reactivation of hepatitis B virus (08.01.05)
link in drug section NICE TA763: Daratumumab in combination for untreated multiple myeloma when a stem cell transplant is suitable (08.01.05)
link in drug section NICE TA783: Daratumumab monotherapy for treating relapsed and refractory multiple myeloma (08.01.05)
link in drug section NICE TA897: Daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma (08.01.05)
link in drug section NICE TA917: Daratumumab with lenalidomide and dexamethasone for untreated multiple myeloma when a stem cell transplant is unsuitable (08.01.05)


 
netFormulary